/NXGL
NXGL Stock - NEXGEL, Inc.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$1.62-1.22%
$0.02 (-1.22%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.4
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.96
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.78
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NXGL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.60 – $1.64
TARGET (TP)$1.86
STOP LOSS$1.49
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.59
52W High$4.95
52W Low$1.45
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $8.69M | $4.09M | $2.05M | $1.55M | $674,000 |
| Gross Profit | $2.75M | $374,000 | $256,000 | $8,000 | $-291,000 |
| Gross Margin | 31.6% | 9.1% | 12.5% | 0.5% | -43.2% |
| Operating Income | $-3,554,000 | $-3,477,000 | $-3,348,000 | $-2,570,000 | $-2,260,000 |
| Net Income | $-3,281,000 | $-3,157,000 | $-4,746,000 | $-4,310,000 | $-2,264,000 |
| Net Margin | -37.8% | -77.2% | -231.7% | -277.9% | -335.9% |
| EPS | $-0.50 | $-0.56 | $-0.85 | $-0.77 | $-0.41 |
Company Overview
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NXGLBeat Rate
50%
Last 16 quarters
Avg Surprise
-59.3%
EPS vs Estimate
Beats / Misses
8/7
1 met exactly
Latest EPS
$-0.08
Q4 2025
EPS Surprise History
Q2 24
-72.7%
$-0.19vs$-0.11
Q2 24
+22.2%
$-0.14vs$-0.18
Q3 24
0.0%
$-0.14vs$-0.14
Q4 24
-10.0%
$-0.11vs$-0.10
Q1 25
+20.0%
$-0.08vs$-0.10
Q2 25
+10.0%
$-0.09vs$-0.10
Q3 25
-800.0%
$-0.09vs$-0.01
Q4 25
+11.1%
$-0.08vs$-0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 11, 2025 | $-0.09 | $-0.08 | +11.1% | ✓ BEAT |
Q3 2025 | Aug 12, 2025 | $-0.01 | $-0.09 | -800.0% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-0.10 | $-0.09 | +10.0% | ✓ BEAT |
Q1 2025 | Mar 24, 2025 | $-0.10 | $-0.08 | +20.0% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-0.10 | $-0.11 | -10.0% | ✗ MISS |
Q3 2024 | Aug 19, 2024 | $-0.14 | $-0.14 | 0.0% | = MET |
Q2 2024 | May 13, 2024 | $-0.18 | $-0.14 | +22.2% | ✓ BEAT |
Q2 2024 | Apr 1, 2024 | $-0.11 | $-0.19 | -72.7% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.12 | $-0.10 | +16.7% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.13 | $-0.12 | +7.7% | ✓ BEAT |
Q2 2023 | May 15, 2023 | $-0.14 | $-0.15 | -7.1% | ✗ MISS |
Q1 2023 | Mar 27, 2023 | $-0.15 | $-0.11 | +26.7% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $-0.15 | $-0.22 | -46.7% | ✗ MISS |
Q3 2022 | Aug 10, 2022 | $-0.15 | $-0.19 | -26.7% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-0.15 | $-0.33 | -120.0% | ✗ MISS |
Q1 2022 | Mar 21, 2022 | $-0.37 | $-0.29 | +20.4% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | — | $-0.23 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.15 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.13 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.12 | — | — |
Latest News
NEXGEL Announces Spin-Off Of Drug Delivery Program Into NexGelRx, Shareholders To Receive 19.99% Equity Interest In NexGelRx Up To $8M Of Capital Investment In Spin-Off; NexGelRx Will Also Receive 5% Global royalty on Products Sold Using Its Technology
📈 PositiveBenzinga•Dec 11, 2025, 01:18 PM
NexGel Q3 EPS $(0.08), Inline, Sales $2.930M Miss $3.164M Estimate
➖ NeutralBenzinga•Nov 11, 2025, 09:11 PM
Nexgel Revenue Jumps 100% in Fiscal Q2
📈 PositiveThe Motley Fool•Aug 13, 2025, 02:04 AM
Frequently Asked Questions about NXGL
What is NXGL's current stock price?
NEXGEL, Inc. (NXGL) is currently trading at $1.62 per share. The stock has moved -1.22% today.
What is the analyst price target for NXGL?
No analyst price targets are currently available for this stock.
What sector is NEXGEL, Inc. in?
NEXGEL, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is NXGL's market cap?
NEXGEL, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does NXGL pay dividends?
No, NEXGEL, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorENLV
Enlivex Therapeutics Ltd.
$0.83
Mkt Cap: $0.0B
FEMY
Femasys Inc.
$0.86
Mkt Cap: $0.0B
GDTC
CytoMed Therapeutics Limited
$1.41
Mkt Cap: $0.0B
HBIO
Harvard Bioscience, Inc.
$0.75
Mkt Cap: $0.0B
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$1.02
Mkt Cap: $0.0B
MLSS
Milestone Scientific Inc.
$0.32
Mkt Cap: $0.0B
MTVA
MetaVia Inc.
$8.62
Mkt Cap: $0.0B
NXL
Nexalin Technology, Inc.
$0.83
Mkt Cap: $0.0B
POCI
Precision Optics Corporation, Inc.
$4.08
Mkt Cap: $0.0B
RVP
Retractable Technologies, Inc.
$0.82
Mkt Cap: $0.0B
Explore stocks similar to NXGL for comparison